Bristol-Myers Squibb
BMY
BMY
2,523 hedge funds and large institutions have $126B invested in Bristol-Myers Squibb in 2022 Q2 according to their latest regulatory filings, with 152 funds opening new positions, 960 increasing their positions, 1,060 reducing their positions, and 96 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,523
Holders Change
+21
Holders Change %
+0.84%
% of All Funds
42.66%
Holding in Top 10
132
Holding in Top 10 Change
+47
Holding in Top 10 Change %
+55.29%
% of All Funds
2.23%
New
152
Increased
960
Reduced
1,060
Closed
96
Calls
$2.58B
Puts
$1.98B
Net Calls
+$597M
Net Calls Change
+$206M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
$3.59B |
| 2 |
Capital International Investors
Los Angeles,
California
|
$2.93B |
| 3 |
Morgan Stanley
New York
|
$2.79B |
| 4 |
N
Natixis
Paris,
France
|
$436M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
$5.53B |
